Shipments of tablet form of micronized colestipol cholesterol- lowering medication begin Nov. 1. Colestipol tablets (2 g colestipol q.d./b.i.d.), approved July 19, have the same active ingredient as orange-flavored and regular Celestial Granules ("The Pink Sheet," Aug. 1, In Brief). AWP, according to November's Medi- Span, is $34.38 for 120 1 gram tablets. The tablets are two- thirds the size of BMS' Questran (cholestyramine), Upjohn says. Questran tablets were withdrawn after seven reports of difficulty in swallowing ("The Pink Sheet" Oct. 31, T&G-3). excipients make up 12% of the Colestid tablet, including the coating
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth